Wellington Management Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Wellington Management Group’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-39,164	Closed	-$1.74M	–	2359
2018 Q1	$1.74M	Sell	39,164 -27,520	-41%	-$1.16M	﹤0.01%	1766
2017 Q4	$2.89M	Sell	66,684 -5,341	-7%	-$240K	﹤0.01%	1624
2017 Q3	$3.35M	Hold	72,025	–	–	﹤0.01%	1590
2017 Q2	$3.56M	Hold	72,025	–	–	﹤0.01%	1537
2017 Q1	$3.95M	Hold	72,025	–	–	﹤0.01%	1523
2016 Q4	$4.01M	Hold	72,025	–	–	﹤0.01%	1470
2016 Q3	$3.29M	Hold	72,025	–	–	﹤0.01%	1529
2016 Q2	$2.88M	Buy	72,025 +1,896	+3%	+$69.4K	﹤0.01%	1518
2016 Q1	$2.44M	Buy	70,129 +10,181	+17%	+$374K	﹤0.01%	1551
2015 Q4	$2.58M	Buy	59,948 +41,038	+217%	+$2.06M	﹤0.01%	1558
2015 Q3	$823K	Buy	18,910 +14,163	+298%	+$764K	﹤0.01%	1875
2015 Q2	$245K	Sell	4,747 -5,367	-53%	-$229K	﹤0.01%	2076
2015 Q1	$396K	Hold	10,114	–	–	﹤0.01%	2042
2014 Q4	$391K	Buy	+10,114	New	+$386K	﹤0.01%	2046

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's BSTC Position: Q2 2018 in Review

Wellington Management Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2018, closing a stake of 39,164 shares — an estimated $1.74M sold.

Wellington Management Group first reported a position in BSTC in Q4 2014 and held it in 14 quarters. The position peaked at $4.01M in Q4 2016. 80 funds tracked by Wall St. Rank hold BSTC as of Q2 2018.

Wellington Management Group reported no remaining BioSpecifics Technologies Corp. position as of Q2 2018 after selling out during the quarter.
Wellington Management Group sold 39,164 BioSpecifics Technologies Corp. shares in Q2 2018, an estimated $1.74M.
Wellington Management Group first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 14 quarters.
Wellington Management Group's BioSpecifics Technologies Corp. position peaked at $4.01M in Q4 2016.
80 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2018.

Based on Wellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.